News Ohr Pharma’s Eye Drug Fails in Mid-Stage Study, Shares Plunge by Medscape • 2015/03/30 • 0 Comments Ohr Pharmaceutical Inc said its experimental eye drug failed the main goal in a mid-stage study as a combination therapy, sending the company's shares plunging 64 percent in premarket trading on Friday. Reuters Health Information Full Story →